## Abstract Hepatitis C virus (HCV) genotyping is important for determining the treatment protocol for hepatitis C patients. Since amplified material from the Roche HCV Monitor kit is compatible with the Innogenetics INNO‐LiPA HCV II kit (line probe assay), amplicons from the Monitor assay can be u
Relationship between viral genotype and viral load in patients with chronic hepatitis C
✍ Scribed by F. García; C. Roldàn; J. Hernàndez-Quero; M. C. Bernal; M. A. Martínez; M. A. López; G. Piédrola; M. C. Maroto
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 393 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
I read with interest the timely article by Bugianesi et al. detailing insulin resistance in chronic liver disease. As briefly mentioned in this article, chronic hepatitis C (CHC) is associated with insulin resistance (IR) and the co-existence of NAFLD and IR with CHC is associated with decreased su
Metabolic factors have been associated with liver damage in patients with genotype 1 chronic hepatitis C (G1 CHC). We tested visceral adiposity index (VAI), a new marker of adipose dysfunction in G1 CHC, patients to assess its association with host and viral factors and its link to both histological
To clarify the virological differences in patients with chronic hepatitis C virus (HCV) infection with and without liver damage, we assessed HCV markers in 306 patients from a rural area of Japan. Genotypes of HCV RNA were determined by polymerase chain reaction, and levels of RNA were determined by
## Abstract Most patients with an acute infection of hepatitis C virus (HCV) will develop chronic hepatitis, and only about 15–20% of the cases will resolve spontaneously. The mechanism for the different outcomes in patients with acute HCV infection remains unclear. HCV genotype has been recognized